|
End-of-day quote
Shenzhen S.E.
20/11/2026
|
5-day change | 1st Jan Change | ||
| 136.58 CNY | -3.27% |
|
-10.54% | +46.97% |
| 12/11 | Asymchem Laboratories Co., Ltd. announces an Equity Buyback for CNY 700 million worth of its shares. | CI |
| 12/11 | Asymchem Laboratories Co., Ltd. authorizes a Buyback Plan. | CI |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,11,228 | 52,704 | 41,387 | 26,238 | 32,605 | 47,775 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 46.53% | - | - |
| Enterprise Value (EV) 1 | 1,05,383 | 47,524 | 34,318 | 20,491 | 26,337 | 43,989 | 44,932 | 45,784 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 67.02% | 2.14% | 1.9% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 37.1x | 27.7x | 21.5x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 2.63x | 2.46x | 2.27x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.3x | 0.8x | 0.7x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 5.91x | 4.83x | 3.96x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 5.44x | 4.54x | 3.79x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 21.2x | 17.1x | 14x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 28.9x | 22.5x | 18.4x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -36.9x | 146x | 49.1x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -2.71% | 0.69% | 2.04% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.319 | 1.837 | 2.215 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.97% | 1.35% | 1.62% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.68 | 4.929 | 6.353 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 35.8% | 37.3% | 34.9% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,083 | 9,900 | 12,070 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,073 | 2,635 | 3,271 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,520 | 1,998 | 2,484 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,325 | 1,779 | 2,292 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -3,786 | -2,843 | -1,991 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 136.58 | 136.58 | 136.58 |
| Nbr of stocks (in thousands) | 3,68,307 | 3,64,755 | 3,64,426 | 3,54,879 | 3,59,442 | 3,59,630 | - | - |
| Announcement Date | 30/03/22 | 30/03/23 | 28/03/24 | 28/03/25 | 30/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 38.37x | 5.65x | 22.02x | 0.93% | 740.49Cr | ||
| 39.52x | 13.4x | 28.41x | 0.5% | 1,20400Cr | ||
| 36.48x | 6.57x | 18.48x | 1.99% | 64TCr | ||
| 36.15x | 8.33x | 17.22x | 2.43% | 50TCr | ||
| 21.54x | 5.2x | 13.03x | 2.51% | 38TCr | ||
| 94.27x | 5.43x | 23.16x | 2.56% | 33TCr | ||
| 22.77x | 5.51x | 13.41x | 2.89% | 28TCr | ||
| 22.87x | 4.6x | 13.08x | 1.92% | 27TCr | ||
| 22.66x | 7.01x | 12.88x | 2.3% | 24TCr | ||
| -39.16x | 7.25x | 45.68x | 1.98% | 21TCr | ||
| Average | 29.55x | 6.89x | 20.74x | 2% | 41TCr | |
| Weighted average by Cap. | 34.09x | 8.45x | 21.48x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















